Yes, several biomarkers can indicate the status of tumor vascularization. These include levels of VEGF, endothelial cell markers like CD31, and imaging techniques such as dynamic contrast-enhanced MRI (DCE-MRI). These biomarkers can help assess the effectiveness of anti-angiogenic therapies and monitor tumor response.
